Substance abuse and movement disorders
Identifieur interne : 001985 ( Main/Curation ); précédent : 001984; suivant : 001986Substance abuse and movement disorders
Auteurs : John C. M. Brust [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2010-10-15.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- MESH :
- complications : Substance-Related Disorders.
- etiology : Movement Disorders.
- Humans.
Abstract
An array of movement disorders is associated with ethanol, illicit drugs, and tobacco. Heavy ethanol users experience withdrawal tremor and, less often, withdrawal parkinsonism, chorea, and myoclonus. Asterixis is a feature of hepatic failure. On the other hand, ethanol can ameliorate essential tremor and myoclonus‐dystonia. Among opioid drugs, meperidine can precipitate myoclonus. Severe parkinsonism affected users of a synthetic meperidine analog contaminated with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Spongiform leukoencephalopathy, sometimes with chorea and myoclonus, occurred in inhalers of heroin vapor (chasing the dragon). Psychostimulants including cocaine acutely cause stereotypies and dyskinesias. Phencyclidine toxicity causes myoclonus. Tobacco use, on the other hand, protects against Parkinson's disease. Clinicians need to consider substance abuse in patients with unexplained movement disorders. © 2010 Movement Disorder Society.
Url:
DOI: 10.1002/mds.22599
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001237
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :001237
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000664
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001616
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :001616
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001591
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :002E01
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :002E01
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002E01
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :001E21
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000899
- to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :002420
- to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000818
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :002405
Links to Exploration step
ISTEX:D1C76009C21225E4BFF8BE04388D04ABCF2D8274Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Substance abuse and movement disorders</title>
<author><name sortKey="Brust, John C M" sort="Brust, John C M" uniqKey="Brust J" first="John C. M." last="Brust">John C. M. Brust</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D1C76009C21225E4BFF8BE04388D04ABCF2D8274</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1002/mds.22599</idno>
<idno type="url">https://api.istex.fr/document/D1C76009C21225E4BFF8BE04388D04ABCF2D8274/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001237</idno>
<idno type="wicri:Area/Istex/Curation">001237</idno>
<idno type="wicri:Area/Istex/Checkpoint">000664</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Brust J:substance:abuse:and</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:20721928</idno>
<idno type="wicri:Area/PubMed/Corpus">001616</idno>
<idno type="wicri:Area/PubMed/Curation">001616</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001591</idno>
<idno type="wicri:Area/Ncbi/Merge">002E01</idno>
<idno type="wicri:Area/Ncbi/Curation">002E01</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002E01</idno>
<idno type="wicri:Area/Main/Merge">001E21</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:10-0474314</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000899</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002420</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000818</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Brust J:substance:abuse:and</idno>
<idno type="wicri:Area/Main/Merge">002405</idno>
<idno type="wicri:Area/Main/Curation">001985</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Substance abuse and movement disorders</title>
<author><name sortKey="Brust, John C M" sort="Brust, John C M" uniqKey="Brust J" first="John C. M." last="Brust">John C. M. Brust</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Harlem Hospital Center and Columbia, University College of Physicians and Surgeons, New York, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-10-15">2010-10-15</date>
<biblScope unit="vol">25</biblScope>
<biblScope unit="issue">13</biblScope>
<biblScope unit="page" from="2010">2010</biblScope>
<biblScope unit="page" to="2020">2020</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">D1C76009C21225E4BFF8BE04388D04ABCF2D8274</idno>
<idno type="DOI">10.1002/mds.22599</idno>
<idno type="ArticleID">MDS22599</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Ethanol</term>
<term>Heroin</term>
<term>Humans</term>
<term>Movement Disorders (etiology)</term>
<term>Myoclonus</term>
<term>Nervous system diseases</term>
<term>Pethidine</term>
<term>Substance abuse</term>
<term>Substance-Related Disorders (complications)</term>
<term>ethanol</term>
<term>heroin</term>
<term>meperidine</term>
<term>myoclonus</term>
<term>psychostimulant</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Substance-Related Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Movement Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Abus de substance</term>
<term>Ethanol</term>
<term>Héroïne</term>
<term>Myoclonie</term>
<term>Pathologie du système nerveux</term>
<term>Péthidine</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">An array of movement disorders is associated with ethanol, illicit drugs, and tobacco. Heavy ethanol users experience withdrawal tremor and, less often, withdrawal parkinsonism, chorea, and myoclonus. Asterixis is a feature of hepatic failure. On the other hand, ethanol can ameliorate essential tremor and myoclonus‐dystonia. Among opioid drugs, meperidine can precipitate myoclonus. Severe parkinsonism affected users of a synthetic meperidine analog contaminated with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Spongiform leukoencephalopathy, sometimes with chorea and myoclonus, occurred in inhalers of heroin vapor (chasing the dragon). Psychostimulants including cocaine acutely cause stereotypies and dyskinesias. Phencyclidine toxicity causes myoclonus. Tobacco use, on the other hand, protects against Parkinson's disease. Clinicians need to consider substance abuse in patients with unexplained movement disorders. © 2010 Movement Disorder Society.</div>
</front>
</TEI>
<double idat="0885-3185:2010:Brust J:substance:abuse:and"><INIST><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Substance Abuse and Movement Disorders</title>
<author><name sortKey="Brust, John C M" sort="Brust, John C M" uniqKey="Brust J" first="John C. M." last="Brust">John C. M. Brust</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, Harlem Hospital Center and Columbia, University College of Physicians and Surgeons</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">10-0474314</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0474314 INIST</idno>
<idno type="RBID">Pascal:10-0474314</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000899</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002420</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000818</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Brust J:substance:abuse:and</idno>
<idno type="wicri:Area/Main/Merge">002405</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Substance Abuse and Movement Disorders</title>
<author><name sortKey="Brust, John C M" sort="Brust, John C M" uniqKey="Brust J" first="John C. M." last="Brust">John C. M. Brust</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Neurology, Harlem Hospital Center and Columbia, University College of Physicians and Surgeons</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Ethanol</term>
<term>Heroin</term>
<term>Myoclonus</term>
<term>Nervous system diseases</term>
<term>Pethidine</term>
<term>Substance abuse</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Abus de substance</term>
<term>Myoclonie</term>
<term>Pathologie du système nerveux</term>
<term>Ethanol</term>
<term>Héroïne</term>
<term>Péthidine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">An array of movement disorders is associated with ethanol, illicit drugs, and tobacco. Heavy ethanol users experience withdrawal tremor and, less often, withdrawal parkinsonism, chorea, and myoclonus. Asterixis is a feature of hepatic failure. On the other hand, ethanol can ameliorate essential tremor and myoclonus-dystonia. Among opioid drugs, meperidine can precipitate myoclonus. Severe parkinsonism affected users of a synthetic meperidine analog contaminated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Spongiform leukoencephalopathy, sometimes with chorea and myoclonus, occurred in inhalers of heroin vapor (chasing the dragon). Psychostimulants including cocaine acutely cause stereotypies and dyskinesias. Phencyclidine toxicity causes myoclonus. Tobacco use, on the other hand, protects against Parkinson's disease. Clinicians need to consider substance abuse in patients with unexplained movement disorders.</div>
</front>
</TEI>
</INIST>
<ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Substance abuse and movement disorders</title>
<author><name sortKey="Brust, John C M" sort="Brust, John C M" uniqKey="Brust J" first="John C. M." last="Brust">John C. M. Brust</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D1C76009C21225E4BFF8BE04388D04ABCF2D8274</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1002/mds.22599</idno>
<idno type="url">https://api.istex.fr/document/D1C76009C21225E4BFF8BE04388D04ABCF2D8274/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001237</idno>
<idno type="wicri:Area/Istex/Curation">001237</idno>
<idno type="wicri:Area/Istex/Checkpoint">000664</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Brust J:substance:abuse:and</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:20721928</idno>
<idno type="wicri:Area/PubMed/Corpus">001616</idno>
<idno type="wicri:Area/PubMed/Curation">001616</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001591</idno>
<idno type="wicri:Area/Ncbi/Merge">002E01</idno>
<idno type="wicri:Area/Ncbi/Curation">002E01</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002E01</idno>
<idno type="wicri:Area/Main/Merge">001E21</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Substance abuse and movement disorders</title>
<author><name sortKey="Brust, John C M" sort="Brust, John C M" uniqKey="Brust J" first="John C. M." last="Brust">John C. M. Brust</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Harlem Hospital Center and Columbia, University College of Physicians and Surgeons, New York, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010-10-15">2010-10-15</date>
<biblScope unit="vol">25</biblScope>
<biblScope unit="issue">13</biblScope>
<biblScope unit="page" from="2010">2010</biblScope>
<biblScope unit="page" to="2020">2020</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">D1C76009C21225E4BFF8BE04388D04ABCF2D8274</idno>
<idno type="DOI">10.1002/mds.22599</idno>
<idno type="ArticleID">MDS22599</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Humans</term>
<term>Movement Disorders (etiology)</term>
<term>Substance-Related Disorders (complications)</term>
<term>ethanol</term>
<term>heroin</term>
<term>meperidine</term>
<term>myoclonus</term>
<term>psychostimulant</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Substance-Related Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Movement Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">An array of movement disorders is associated with ethanol, illicit drugs, and tobacco. Heavy ethanol users experience withdrawal tremor and, less often, withdrawal parkinsonism, chorea, and myoclonus. Asterixis is a feature of hepatic failure. On the other hand, ethanol can ameliorate essential tremor and myoclonus‐dystonia. Among opioid drugs, meperidine can precipitate myoclonus. Severe parkinsonism affected users of a synthetic meperidine analog contaminated with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine. Spongiform leukoencephalopathy, sometimes with chorea and myoclonus, occurred in inhalers of heroin vapor (chasing the dragon). Psychostimulants including cocaine acutely cause stereotypies and dyskinesias. Phencyclidine toxicity causes myoclonus. Tobacco use, on the other hand, protects against Parkinson's disease. Clinicians need to consider substance abuse in patients with unexplained movement disorders. © 2010 Movement Disorder Society.</div>
</front>
</TEI>
</ISTEX>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001985 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001985 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:D1C76009C21225E4BFF8BE04388D04ABCF2D8274 |texte= Substance abuse and movement disorders }}
This area was generated with Dilib version V0.6.23. |